van Leeuwen R - Search Results

1

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.

Wit FW, van Leeuwen R, Weverling GJ, Jurriaans S, Nauta K, Steingrover R, Schuijtemaker J, Eyssen X, Fortuin D, Weeda M, de Wolf F, Reiss P, Danner SA, Lange JM. Wit FW, et al. Among authors: van leeuwen r. J Infect Dis. 1999 Apr;179(4):790-8. doi: 10.1086/314675. J Infect Dis. 1999. PMID: 10068573

2

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

Schuurman R, Nijhuis M, van Leeuwen R, Schipper P, de Jong D, Collis P, Danner SA, Mulder J, Loveday C, Christopherson C, et al. Schuurman R, et al. Among authors: van leeuwen r. J Infect Dis. 1995 Jun;171(6):1411-9. doi: 10.1093/infdis/171.6.1411. J Infect Dis. 1995. PMID: 7539472

3

Treatment of HIV infection. Tolerability of commonly used antiretroviral agents.

Notermans DW, van Leeuwen R, Lange JM. Notermans DW, et al. Among authors: van leeuwen r. Drug Saf. 1996 Sep;15(3):176-87. doi: 10.2165/00002018-199615030-00003. Drug Saf. 1996. PMID: 8879972 Review.

4

Additive or sequential nucleoside analogue therapy compared with continued zidovudine monotherapy in human immunodeficiency virus-infected patients with advanced disease does not prolong survival: an observational study.

van Leeuwen R, Bonsel GJ, Reiss P, Danner SA, Lange JM. van Leeuwen R, et al. J Infect Dis. 1997 Jun;175(6):1344-51. doi: 10.1086/516466. J Infect Dis. 1997. PMID: 9180173 Clinical Trial.

5

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.

Reijers MH, Weverling GJ, Jurriaans S, Wit FW, Weigel HM, Ten Kate RW, Mulder JW, Frissen PH, van Leeuwen R, Reiss P, Schuitemaker H, de Wolf F, Lange JM. Reijers MH, et al. Among authors: van leeuwen r. Lancet. 1998 Jul 18;352(9123):185-90. doi: 10.1016/s0140-6736(98)06193-5. Lancet. 1998. PMID: 9683207 Clinical Trial.

6

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis.

Koot M, van Leeuwen R, de Goede RE, Keet IP, Danner S, Eeftinck Schattenkerk JK, Reiss P, Tersmette M, Lange JM, Schuitemaker H. Koot M, et al. Among authors: van leeuwen r. J Infect Dis. 1999 Jan;179(1):254-8. doi: 10.1086/314539. J Infect Dis. 1999. PMID: 9841850

7

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.

den Brinker M, Wit FW, Wertheim-van Dillen PM, Jurriaans S, Weel J, van Leeuwen R, Pakker NG, Reiss P, Danner SA, Weverling GJ, Lange JM. den Brinker M, et al. Among authors: van leeuwen r. AIDS. 2000 Dec 22;14(18):2895-902. doi: 10.1097/00002030-200012220-00011. AIDS. 2000. PMID: 11153671 Clinical Trial.

8

Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine.

van Leeuwen R, Lange JM, Nijhuis M, Schuurman R, Reiss P, Danner SA, Boucher CA. van Leeuwen R, et al. Antivir Ther. 1997 Apr;2(2):79-90. Antivir Ther. 1997. PMID: 11322279

9

The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons.

Veldkamp AI, Harris M, Montaner JS, Moyle G, Gazzard B, Youle M, Johnson M, Kwakkelstein MO, Carlier H, van Leeuwen R, Beijnen JH, Lange JM, Reiss P, Hoetelmans RM. Veldkamp AI, et al. Among authors: van leeuwen r. J Infect Dis. 2001 Jul 1;184(1):37-42. doi: 10.1086/320998. Epub 2001 May 30. J Infect Dis. 2001. PMID: 11398107 Clinical Trial.

10

Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.

Pakker NG, Roos MT, van Leeuwen R, de Jong MD, Koot M, Reiss P, Lange JM, Miedema F, Danner SA, Schellekens PT. Pakker NG, et al. Among authors: van leeuwen r. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15;16(5):318-26. doi: 10.1097/00042560-199712150-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9420308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters